MARKET

SRZN

SRZN

Surrozen Inc
NASDAQ
7.10
+0.25
+3.65%
After Hours: 7.10 0 0.00% 16:05 05/16 EDT
OPEN
6.21
PREV CLOSE
6.85
HIGH
7.27
LOW
5.90
VOLUME
50.02K
TURNOVER
--
52 WEEK HIGH
18.17
52 WEEK LOW
5.90
MARKET CAP
60.79M
P/E (TTM)
-0.3276
1D
5D
1M
3M
1Y
5Y
1D
Surrozen Holds Successful 2025 Annual Stockholders Meeting
TipRanks · 2d ago
Surrozen Granted US Patent To Antibody-Based Molecules Targeting Key Receptors In Wnt Pathway
Benzinga · 4d ago
Surrozen granted patent from USPTO directed to antibody-based molecules
TipRanks · 4d ago
SURROZEN GRANTED PATENT FROM U.S. PATENT AND TRADEMARK OFFICE DIRECTED TO ANTIBODY-BASED MOLECULES TARGETING KEY RECEPTORS IN THE WNT PATHWAY
Reuters · 4d ago
Weekly Report: what happened at SRZN last week (0505-0509)?
Weekly Report · 6d ago
Surrozen’s Strategic Focus on Wnt Pathway and Promising Pipeline Earns Buy Rating
TipRanks · 6d ago
Surrozen, Inc. Reports Q1 2025 Financial Results
TipRanks · 05/10 04:12
Form 10-Q for Surrozen, Inc. for the quarterly period ended March 31, 2025
Press release · 05/09 22:43
More
About SRZN
Surrozen, Inc. is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. The Company is developing tissue-specific antibodies designed to engage the body’s existing biological repair mechanisms with a focus in ophthalmology. Its product candidates include SZN-8141 for Retinal Diseases, SZN-8143 for Retinal Diseases, SZN-113 for Fuchs’ Endothelial Corneal Dystrophy and Geographic Atrophy, and SZN-413 for Retinal Diseases. SZN-8141 combines Frizzled 4 (Fzd4) agonism and Vascular Endothelial Growth Factor (VEGF) antagonism which has the potential to provide benefits over treatment with single agents for Diabetic Macular Edema (DME) and neovascular Age Related Macular Degeneration (wet AMD). SZN-8143 combines Fzd4 agonism, VEGF antagonism, and interleukin-6 (IL-6) antagonism which may have benefits over single agents for treatment of DME/wet AMD/uveitic macular edema. SZN-413 is a bi-specific antibody, designed using its SWAP technology.

Webull offers Surrozen Inc stock information, including NASDAQ: SRZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SRZN stock methods without spending real money on the virtual paper trading platform.